IXHL
Incannex Healthcare Inc
NASDAQ · Pharmaceuticals
$0.29
+0.04 (+15.20%)
Open$0.26
Previous Close$0.25
Day High$0.30
Day Low$0.26
52W High$40.76
52W Low$19.98
Volume—
Avg Volume624.4K
Market Cap99.71M
P/E Ratio24.54
EPS$1.17
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 24.18M | 25.07M | 24.10M |
| Net Income | 3.50M | 4.81M | 4.53M |
| Profit Margin | 14.5% | 19.2% | 18.8% |
| EBITDA | 6.33M | 6.46M | 6.22M |
| Free Cash Flow | 2.28M | 4.01M | 3.85M |
| Rev Growth | +8.0% | +16.3% | +6.8% |
| Debt/Equity | 0.73 | 0.71 | 0.70 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |